spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Lyase PDB id
1tl7
Jmol
Contents
Protein chains
189 a.a. *
189 a.a. *
330 a.a. *
Ligands
FOK
ONM
GSP
Metals
_MN ×2
_MG
_CL
Waters ×18
* Residue conservation analysis
PDB id:
1tl7
Name: Lyase
Title: Complex of gs- with the catalytic domains of mammalian adenylyl cyclase: complex with 2'(3')-o-(n- methylanthraniloyl)-guanosine 5'-triphosphate and mn
Structure: Adenylate cyclase, type v. Chain: a. Fragment: c1a domain of adenylyl cyclase. Synonym: atp pyrophosphate-lyase, ca2+, -inhibitable adenylyl cyclase. Engineered: yes. Adenylate cyclase, type ii. Chain: b. Fragment: c2a domain of adenylyl cyclase.
Source: Canis lupus familiaris. Dog. Organism_taxid: 9615. Strain: familiaris. Gene: name=adcy5. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Rattus norvegicus. Norway rat.
Biol. unit: Trimer (from PQS)
Resolution:
2.80Å     R-factor:   0.254     R-free:   0.298
Authors: T.C.Mou,A.Gille,R.J.Seifert,S.R.Sprang
Key ref:
T.C.Mou et al. (2005). Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate. J Biol Chem, 280, 7253-7261. PubMed id: 15591060 DOI: 10.1074/jbc.M409076200
Date:
09-Jun-04     Release date:   14-Dec-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P30803  (ADCY5_CANFA) -  Adenylate cyclase type 5
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1265 a.a.
189 a.a.*
Protein chain
Pfam   ArchSchema ?
P26769  (ADCY2_RAT) -  Adenylate cyclase type 2
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1090 a.a.
189 a.a.
Protein chain
Pfam   ArchSchema ?
P04896  (GNAS2_BOVIN) -  Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
Seq:
Struc:
394 a.a.
330 a.a.
Key:    PfamA domain  PfamB domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains A, B: E.C.4.6.1.1  - Adenylate cyclase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP = 3',5'-cyclic AMP + diphosphate
ATP
Bound ligand (Het Group name = ONM)
matches with 73.00% similarity
=
3',5'-cyclic AMP
Bound ligand (Het Group name = GSP)
matches with 68.00% similarity
+ diphosphate
      Cofactor: Pyridoxal 5'-phosphate
Pyridoxal 5'-phosphate
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   5 terms 
  Biological process     intracellular signal transduction   25 terms 
  Biochemical function     nucleotide binding     10 terms  

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M409076200 J Biol Chem 280:7253-7261 (2005)
PubMed id: 15591060  
 
 
Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
T.C.Mou, A.Gille, D.A.Fancy, R.Seifert, S.R.Sprang.
 
  ABSTRACT  
 
Membrane-bound mammalian adenylyl cyclase (mAC) catalyzes the synthesis of intracellular cyclic AMP from ATP and is activated by stimulatory G protein alpha subunits (Galpha(s)) and by forskolin (FSK). mACs are inhibited with high potency by 2 '(3')-O-(N-methylanthraniloyl) (MANT)-substituted nucleotides. In this study, the crystal structures of the complex between Galpha(s).GTPgammaS and the catalytic C1 and C2 domains from type V and type II mAC (VC1.IIC2), bound to FSK and either MANT-GTP.Mg(2+) or MANT-GTP.Mn(2+) have been determined. MANT-GTP coordinates two metal ions and occupies the same position in the catalytic site as P-site inhibitors and substrate analogs. However, the orientation of the guanine ring is reversed relative to that of the adenine ring. The MANT fluorophore resides in a hydrophobic pocket at the interface between the VC1 and IIC2 domains and prevents mAC from undergoing the "open" to "closed" domain rearrangement. The K(i) of MANT-GTP for inhibition of VC1.IIC2 is lower in the presence of mAC activators and lower in the presence of Mn(2+) compared with Mg(2+), indicating that the inhibitor binds more tightly to the catalytically most active form of the enzyme. Fluorescence resonance energy transfer-stimulated emission from the MANT fluorophore upon excitation of Trp-1020 in the MANT-binding pocket of IIC2 is also stronger in the presence of FSK. Mutational analysis of two non-conserved amino acids in the MANT-binding pocket suggests that residues outside of the binding site influence isoform selectivity toward MANT-GTP.
 
  Selected figure(s)  
 
Figure 1.
FIG. 1. Global and detailed views of G [s]·VC1·IIC2 complex with MANT-GTP. A, complex of G [s]-activated mAC with MANT-GTP and two Mn2+ ions in the catalytic site. FSK, MANT-GTP, and two metal ions are bound in the ventral cleft between the C1 and C2 domains. The following coloring scheme is used here and in Figs. 2 and 3: the VC1 and IIC2 domains are colored tan and mauve, respectively; the switch II helix of G [s]·GTP S is shown as a red cylinder; FSK and MANT-GTP are drawn as stick models; carbon atoms are gray, nitrogen atoms are blue, oxygen atoms are red, phosphorus atoms are green, and the two Mn2+ ions are shown as metallic orange spheres. B, substrate-binding site of VC1·IIC2 showing MANT-GTP and two Mn2+ ions. Secondary structure elements are labeled as defined previously (16). The positions of the 1- 1- 2 and 3- 4 of VC1 and 7'- 8' of IIC2 in the mAC complex with (closed conformation) or without (open conformation) the competitive inhibitor, -L-2',3'-dd-5'-ATP (Protein Data Bank codes 1CJU [PDB] and 1AZS, respectively) (16, 23), were superimposed and depicted as transparent, rose- and gray-colored elements, respectively. C, interactions are shown among protein residues, MANT-GTP, and two metal ions in the VC1·IIC2 substrate-binding site. MANT-GTP and protein residues are shown as stick models. Stick models of -L-2',3'-dd-5'-ATP and selected side chains in Asn-1025 in 1CJU (see A) are shown in yellow. The gray dashed lines depict the hydrogen bonds between MANT-GTP and protein residues and coordination of the metal ions at sites A and B (see text). Because of the high thermal parameters of the nucleotide (see text), the hydrogen bond distances are approximate. The coordination between metal ions and MANT-GTP is similar to that in the complex with -L-2',3'-dd-5'-ATP; metal A has four ligands, whereas metal B has five ligands. D, detailed view of the purine-binding pocket in the mAC substrate-binding site (see text) The superimposed adenosine group of -L-2',3'-dd-5'-ATP is shown in yellow. The distances of hydrogen bond between guanine ring and surrounding protein residues are as indicated.
Figure 2.
FIG. 2. Difference electron density for 3·-O-MANT-GTP in complex with G [s]·VC1·IIC2. The complexes formed in the presence with Mn2+ or Mg2+ are shown in A and B, respectively. The blue wire cage corresponds to |F[o]| - |F[c]| electron density contoured at 2.5 . Coordinates for MANT-GTP and the two metal ions were omitted from the phasing model.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2005, 280, 7253-7261) copyright 2005.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21279330 M.Erdorf, and R.Seifert (2011).
Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.
  Naunyn Schmiedebergs Arch Pharmacol, 383, 357-372.  
21484439 M.Hübner, S.Dizayee, J.Matthes, R.Seifert, and S.Herzig (2011).
Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes.
  Naunyn Schmiedebergs Arch Pharmacol, 383, 573-583.  
20018863 M.T.Mazhab-Jafari, C.B.Marshall, M.Smith, G.M.Gasmi-Seabrook, V.Stambolic, R.Rottapel, B.G.Neel, and M.Ikura (2010).
Real-time NMR study of three small GTPases reveals that fluorescent 2'(3')-O-(N-methylanthraniloyl)-tagged nucleotides alter hydrolysis and exchange kinetics.
  J Biol Chem, 285, 5132-5136.  
19638320 B.Pavan, C.Biondi, and A.Dalpiaz (2009).
Adenylyl cyclases as innovative therapeutic goals.
  Drug Discov Today, 14, 982-991.  
19447224 C.Pinto, M.Hübner, A.Gille, M.Richter, T.C.Mou, S.R.Sprang, and R.Seifert (2009).
Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.
  Biochem Pharmacol, 78, 62-69.  
19056899 H.M.Taha, J.Schmidt, M.Göttle, S.Suryanarayana, Y.Shen, W.J.Tang, A.Gille, J.Geduhn, B.König, S.Dove, and R.Seifert (2009).
Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides.
  Mol Pharmacol, 75, 693-703.  
19337273 S.Pierre, T.Eschenhagen, G.Geisslinger, and K.Scholich (2009).
Capturing adenylyl cyclases as potential drug targets.
  Nat Rev Drug Discov, 8, 321-335.  
19492438 S.Suryanarayana, J.L.Wang, M.Richter, Y.Shen, W.J.Tang, G.H.Lushington, and R.Seifert (2009).
Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor.
  Biochem Pharmacol, 78, 224-230.  
19494187 S.Suryanarayana, M.Göttle, M.Hübner, A.Gille, T.C.Mou, S.R.Sprang, M.Richter, and R.Seifert (2009).
Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.
  J Pharmacol Exp Ther, 330, 687-695.  
19243146 T.C.Mou, N.Masada, D.M.Cooper, and S.R.Sprang (2009).
Structural basis for inhibition of mammalian adenylyl cyclase by calcium.
  Biochemistry, 48, 3387-3397.
PDB codes: 3c14 3c15 3c16 3e8a 3maa
18630896 C.Schlicker, A.Rauch, K.C.Hess, B.Kachholz, L.R.Levin, J.Buck, and C.Steegborn (2008).
Structure-based development of novel adenylyl cyclase inhibitors.
  J Med Chem, 51, 4456-4464.  
17329110 J.L.Wang, J.X.Guo, Q.Y.Zhang, J.J.Wu, R.Seifert, and G.H.Lushington (2007).
A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.
  Bioorg Med Chem, 15, 2993-3002.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.